News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,998 Results
Type
Article (41358)
Company Profile (298)
Press Release (683332)
Multimedia
Podcasts (89)
Webinars (17)
Section
Business (205806)
Career Advice (2035)
Deals (35683)
Drug Delivery (112)
Drug Development (81634)
Employer Resources (173)
FDA (16468)
Job Trends (15007)
News (347996)
Policy (32863)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2587)
Accelerated approval (31)
Adcomms (24)
Allergies (137)
Alliances (50004)
ALS (168)
Alzheimer's disease (1666)
Antibody-drug conjugate (ADC) (309)
Approvals (16731)
Artificial intelligence (508)
Autoimmune disease (145)
Automation (37)
Bankruptcy (366)
Best Places to Work (11665)
BIOSECURE Act (21)
Biosimilars (188)
Biotechnology (191)
Bladder cancer (158)
Brain cancer (55)
Breast cancer (634)
Cancer (4770)
Cardiovascular disease (399)
Career advice (1719)
Career pathing (35)
CAR-T (278)
CDC (45)
Celiac Disease (2)
Cell therapy (740)
Cervical cancer (36)
Clinical research (69679)
Collaboration (1695)
Company closure (4)
Compensation (1139)
Complete response letters (52)
COVID-19 (2726)
CRISPR (88)
C-suite (824)
Cystic fibrosis (145)
Data (6157)
Decentralized trials (2)
Denatured (30)
Depression (132)
Diabetes (497)
Diagnostics (6709)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (247)
Drug pricing (187)
Drug shortages (28)
Duchenne muscular dystrophy (225)
Earnings (90205)
Editorial (55)
Employer branding (21)
Employer resources (151)
Events (117824)
Executive appointments (968)
FDA (19555)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1464)
Gene editing (196)
Generative AI (43)
Gene therapy (587)
GLP-1 (970)
Government (4670)
Grass and pollen (6)
Guidances (383)
Healthcare (18912)
HIV (55)
Huntington's disease (45)
IgA nephropathy (81)
Immunology and inflammation (253)
Immuno-oncology (55)
Indications (104)
Infectious disease (2989)
Inflammatory bowel disease (190)
Inflation Reduction Act (16)
Influenza (112)
Intellectual property (243)
Interviews (315)
IPO (16681)
IRA (51)
Job creations (3679)
Job search strategy (1439)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (556)
Leadership (30)
Legal (7987)
Liver cancer (91)
Longevity (14)
Lung cancer (639)
Lymphoma (371)
Machine learning (42)
Management (59)
Manufacturing (781)
MASH (161)
Medical device (13806)
Medtech (13858)
Mergers & acquisitions (20058)
Metabolic disorders (1262)
Multiple sclerosis (155)
NASH (16)
Neurodegenerative disease (310)
Neuropsychiatric disorders (87)
Neuroscience (2880)
Neurotech (1)
NextGen: Class of 2026 (6568)
Non-profit (4525)
Now hiring (65)
Obesity (591)
Opinion (260)
Ovarian cancer (165)
Pain (197)
Pancreatic cancer (225)
Parkinson's disease (280)
Partnered (35)
Patents (487)
Patient recruitment (472)
Peanut (55)
People (59229)
Pharmaceutical (66)
Pharmacy benefit managers (29)
Phase 1 (21742)
Phase 2 (30654)
Phase 3 (22856)
Pipeline (5086)
Policy (281)
Postmarket research (2567)
Preclinical (9235)
Press Release (64)
Prostate cancer (234)
Psychedelics (47)
Radiopharmaceuticals (277)
Rare diseases (823)
Real estate (6011)
Recruiting (69)
Regulatory (24525)
Reports (51)
Research institute (2396)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (19)
RSV (76)
Schizophrenia (146)
Series A (245)
Series B (186)
Service/supplier (13)
Sickle cell disease (99)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3681)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (85)
The Weekly (57)
Vaccines (990)
Venture capital (89)
Weight loss (383)
Women's health (87)
Worklife (18)
Date
Today (15)
Last 7 days (598)
Last 30 days (2343)
Last 365 days (30005)
2026 (2839)
2025 (30377)
2024 (35379)
2023 (40215)
2022 (51332)
2021 (55879)
2020 (54204)
2019 (46719)
2018 (35170)
2017 (32271)
2016 (31674)
2015 (37761)
2014 (31487)
2013 (26536)
2012 (28799)
2011 (29476)
2010 (27569)
Location
Africa (740)
Alabama (83)
Alaska (7)
Arizona (305)
Arkansas (13)
Asia (39514)
Australia (6463)
California (11213)
Canada (3254)
China (1085)
Colorado (473)
Connecticut (470)
Delaware (332)
Europe (85150)
Florida (1660)
Georgia (353)
Hawaii (3)
Idaho (62)
Illinois (854)
India (63)
Indiana (516)
Iowa (22)
Japan (418)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1372)
Massachusetts (8042)
Michigan (319)
Minnesota (626)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (79)
New Jersey (2969)
New Mexico (30)
New York (2943)
North Carolina (1441)
North Dakota (8)
Northern California (5463)
Ohio (331)
Oklahoma (21)
Oregon (42)
Pennsylvania (2254)
Puerto Rico (22)
Rhode Island (48)
South America (1111)
South Carolina (65)
South Dakota (1)
Southern California (4358)
Tennessee (172)
Texas (1730)
United States (39709)
Utah (333)
Vermont (1)
Virginia (258)
Washington D.C. (82)
Washington State (918)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
724,998 Results for "flagship biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
In his annual letter, Flagship Pioneering’s Noubar Afeyan lays out a choice between near-term “human-made miracles” and a reversion to the pain and suffering of past diseases due to “growing contempt” in the U.S. for the scientific method.
January 12, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Novartis breaks ground on flagship manufacturing hub in North Carolina
December 12, 2025
·
7 min read
Press Releases
Novartis announces plans to build flagship manufacturing hub in North Carolina
November 20, 2025
·
5 min read
Cardiovascular disease
Novartis Makes Potential $750M+ Bet Per Cardiovascular Disease Target in Another Flagship Pact
Flagship Pioneering’s ProFound Therapeutics will use its proprietary technology to mine the expanded proteome for novel cardiovascular therapeutics. Novartis has promised to pay up to $750 million per target, though it has not specified how many targets it will go after.
June 26, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Flagship Pioneering Announces New Agreements with ProFound Therapeutics and Quotient Therapeutics Under its Collaboration with GSK
November 21, 2025
·
5 min read
Press Releases
Flagship Pioneering and Repertoire® Immune Medicines Announce Agreement to Identify T Cell-Targeted Immune Medicines for Prostate Cancer Under Strategic Partnership with Pfizer
December 23, 2025
·
4 min read
Press Releases
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds
January 26, 2026
·
5 min read
Press Releases
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
January 9, 2026
·
3 min read
Press Releases
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
January 27, 2026
·
5 min read
Press Releases
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
January 15, 2026
·
6 min read
1 of 72,500
Next
